Sell Your Specialty Finance Company
Specialty finance sits at the intersection of credit expertise, regulatory complexity, and technology-driven origination. Institutional buyers and PE-backed platforms are actively consolidating niche lenders, asset-backed originators, and structured credit providers across the United States.
FISART advises specialty finance owners who want a disciplined sale process that reaches the right buyers. We understand how acquirers underwrite portfolio credit quality, regulatory licenses, funding structures, and origination technology. That knowledge translates directly into stronger positioning and better outcomes for sellers.
Schedule a Confidential Consultation6 to 10x EBITDA
150+ acquirers
5 to 7 months
Active consolidation
Why Specialty Finance Is Attracting Institutional Capital
Specialty finance is consolidating rapidly. Large banks retrenched from niche lending after 2008, creating white space that independent originators filled with superior technology, faster underwriting, and deep vertical expertise. Those same independents are now the acquisition targets.
Private equity has committed significant capital to financial services platforms. Sponsors acquire specialty lenders for their contractual cash flows, underwriting IP, and regulatory licenses. Once a platform is established, each add-on acquisition creates operating leverage through shared servicing, compliance infrastructure, and funding facilities.
Technology is accelerating the consolidation thesis. Buyers pay meaningful premiums for companies with automated origination, proprietary scoring models, and servicing platforms that scale without proportional headcount growth. Manual, relationship-driven lenders trade at lower multiples because they are harder to integrate and scale.
Regulatory licenses represent a structural moat. State lending licenses, federal charters, and specialized authorizations take years to obtain. Acquiring a licensed platform is significantly faster than building one from scratch, which keeps buyer demand strong for well-run, compliant specialty finance companies.
What buyers evaluate first
- Portfolio credit quality and loss-rate history across cycles
- Regulatory licenses and compliance infrastructure maturity
- Technology stack and origination automation capabilities
- Funding source diversification and warehouse line stability
- Customer concentration and contract renewal rates
- Scalability of underwriting models and servicing operations
Who Acquires Specialty Finance Companies
The buyer universe includes strategic financial institutions, PE-backed platforms, patient family office capital, and experienced independent operators.
Strategic acquirers
Large banks, diversified financial services companies, and insurance groups acquiring specialty lenders to expand product lines, enter new asset classes, or add distribution channels without building from scratch.
PE firms with financial services platforms
Private equity sponsors running buy-and-build strategies in specialty finance. They professionalize origination, centralize servicing, and consolidate niche lenders into scalable platforms with institutional-grade compliance.
Family offices
Patient capital investors seeking yield-oriented businesses with contractual cash flows, low correlation to public markets, and regulatory moats that protect margins over long holding periods.
Search funds and independent sponsors
Experienced operators acquiring specialty finance businesses with strong unit economics, proven credit models, and clear paths to operational leverage through technology and geographic expansion.
How Specialty Finance Businesses Are Valued
Specialty finance companies typically trade between 6 and 10x EBITDA. The range depends on portfolio quality, funding diversity, regulatory standing, and technology infrastructure. Companies with audited track records across at least one credit cycle command the upper end.
Portfolio composition matters as much as top-line growth. Buyers discount portfolios with concentrated borrower exposure, thin loss-rate data, or geographic concentration. Conversely, diversified collateral pools, granular loan-level data, and consistent vintage performance support premium pricing.
We help sellers normalize earnings, quantify the value of their regulatory licenses, and present origination technology in terms that institutional buyers and PE sponsors can underwrite with confidence.
Key valuation factors
- Portfolio credit quality and loss-rate history across cycles
- Regulatory licenses and compliance infrastructure maturity
- Technology stack and origination automation capabilities
- Funding source diversification and warehouse line stability
- Customer concentration and contract renewal rates
- Scalability of underwriting models and servicing operations
Specialty Finance Segments We Cover
FISART advises across the specialty finance landscape. Each segment attracts different buyer profiles and requires tailored positioning.
When a Sale Makes Sense for Your Business
FISART typically works with specialty finance companies that have established origination channels, a documented credit track record, and regulatory infrastructure that buyers can underwrite.
We work with companies where
- You operate a specialty lender or finance company with $5M or more in annual revenue.
- You have a track record of credit performance across at least one full economic cycle.
- You are considering succession, a partial recapitalization, or a full exit within 1 to 3 years.
- You hold the necessary regulatory licenses and maintain a clean compliance history.
- You want clarity on your market value and a disciplined sale process.
Frequently Asked Questions
Direct answers to common questions about selling a specialty finance company.
Get a Confidential Valuation Range
A focused conversation about your portfolio, licenses, and market position. No cost, no commitment. Understand how buyers would evaluate your business today.
Schedule a Confidential Consultation